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Abstract
Background: Multi-drug resistant (MDR) infections have become a major concern in hospitals worldwide. This study
investigates membrane translocation, which is the first step required for drug action on internal bacterial targets. b-lactams,
a major antibiotic class, use porins to pass through the outer membrane barrier of Gram-negative bacteria. Clinical reports
have linked the MDR phenotype to altered membrane permeability including porin modification and efflux pump
expression.
Methodology/Principal Findings: Here influx of b-lactams through the major Enterobacter aerogenes porin Omp36 is
characterized. Conductance measurements through a single Omp36 trimer reconstituted into a planar lipid bilayer allowed
us to count the passage of single b-lactam molecules. Statistical analysis of each transport event yielded the kinetic
parameters of antibiotic travel through Omp36 and distinguishable translocation properties of b-lactams were quantified
for ertapenem and cefepime. Expression of Omp36 in an otherwise porin-null bacterial strain is shown to confer increases in
the killing rate of these antibiotics and in the corresponding bacterial susceptibility.
Conclusions/Significance: We propose the idea of a molecular ‘‘passport’’ that allows rapid transport of substrates through
porins. Deciphering antibiotic translocation provides new insights for the design of novel drugs that may be highly effective
at passing through the porin constriction zone. Such data may hold the key for the next generation of antibiotics capable of
rapid intracellular accumulation to circumvent the further development MDR infections.
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Introduction
One major biological challenge is to understand how the cell
controls the exchange of solutes with its environment and to
decipher the role of membrane transporters in this process [1,2].
This aspect of membrane physiology is a key issue in the field of
infectious diseases. Antibiotic molecules used in clinical regimens,
must penetrate the outer membrane of Gram negative bacteria to
reach their target sites and kill the pathogen [3,4]. Rapid delivery
to achieve the required concentrations of antibiotic molecules at
their internal targets is now an acute objective due to the threat
associated with re-emerging infectious diseases that are resistant to
multiple antibiotics. Multi-drug resistant (MDR) bacterial infec-
tions have become a worldwide problem, particularly in hospital
settings [5–7]. Among the most urgent is the opportunistic
pathogen, Enterobacter aerogenes, responsible for nosocomial infec-
tions able to rapidly develop a MDR phenotype within 5 days of
antibiotherapy [8]. In order to unlock new therapeutic options/
solutions, it is crucial to understand how and how fast antibiotics
interact with bacterial cells and the mechanisms that lead to such
high levels of resistance. There are 3 major characteristics that an
effective antibiotic must exhibit. 1) Rapid and stable accumulation
at the target site; 2) Strong target binding; 3) Stability against
enzymatic attack [9].
The first step of antibiotic interaction with Gram-negative
bacteria is to cross the outer membrane, which forms a protective
barrier against hostile environments [3,4]. The exact mechanism
of uptake across this lipid bilayer by hydrophobic compounds is
poorly understood. The membrane is punctuated by porins, which
are major outer membrane proteins (OMPs) that form water-filled
channels allowing diffusion across the membrane. Clinical studies
show that the general diffusion porins of many enterobacteriaceal
species serve as a major gateway for the passage of b-lactams and
fluoroquinolones [3,4]. Furthermore, alteration of outer mem-
brane permeability, including modification of porin expression has
emerged as a major MDR mechanism in E. aerogenes and other
enterobacterial pathogens [8,10–13]. To improve the transloca-
tion efficiency of future antibiotics, it is vital to understand the
underlying molecular mechanisms of transport.
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The crystal structures of several porins have been determined
and the conserved internal loop 3 constitutes a crucial part of the
porin channel involved in the influx of antibiotics [4,14–17].
Mutations in this region of Omp36 from E. aerogenes and OmpF
and OmpC from E. coli have been shown to confer altered
permeability and susceptibility to various antibiotics [4,16,18–22].
Analysis of these loop 3 mutations has indicated that certain
substitutions induce drastic changes in channel properties due to
the presence of bulky or differentially charged residues [20–22].
Investigation of antibiotic transport through porin channels can
be carried out by insertion of purified porins into planar lipid
bilayers. Quantification of the molecular dialogue between
antibiotic molecules and porin channels can be achieved via
analysis of ion current noise in the presence of antibiotics [17,23].
Measuring the ion current through purified porins reconstituted
into planar lipid bilayers provides information about a number of
structural and functional properties such as pore size and
selectivity [24]. Moreover, the passage of large molecules through
the channel interrupt the ion current causing fluctuation or even
transient blockages of conductance [17,23,25]. Therefore, addition
of various antibiotics to the system can cause interaction
dependent fluctuations in the ion current and report on the
electrophysiological parameters of translocation [17,25].
In this study transport properties through a major E. aerogenes
porin, Omp36 (homologous to E. coli OmpC and to Klebsiella
pneumoniae OmpK36) were investigated. Physiological conditions
within the patient body favor the expression of Omp36 belonging
to the OmpC-family, over OmpF-type porins [10,16,26,27]. This
is therefore the more relevant porin type to consider during
antibiotherapy [4,13]. Here the aim was to quantify the influx of
representative b-lactams through Omp36. The porin was purified
and ion flow through a single trimer reconstituted into a planar
lipid bilayer was measured. The presence of antibiotics caused ion
current fluctuation in a concentration dependent manner. Analysis
of these fluctuations, induced by penetration of the antibiotics into
the channel, allowed crucial information to be obtained about the
transport mechanism. In addition Omp36 was expressed in the
outer membrane of a porin-null E. coli mutant (BL21Domp).
Minimum inhibitory concentration assays were used to assess b-
lactam susceptibility conferred by Omp36 as the sole porin.
Information about the rate of translocation through this porin for
delivery to target sites was further provided by measuring the rate
of decline of colony forming units following exposure to inhibitory
levels of b-lactams.
Results
Evidence and quantification of antibiotic translocation
through Omp36
The omp36 gene was cloned and expressed in the porin-null E.
coli strain BL21Domp [28] (see Text S1, Table S1 and Fig. S1).
Omp36 was purified using ion-exchange chromatography and a
single trimeric porin was reconstituted into artificial lipid
membranes [17,23]. Application of a transmembrane voltage
established an ion current through the channel and, in the absence
of antibiotics, no visible current blockage was detected up to a
voltage of ,150–200 mV (Fig. 1a). Addition of antibiotics to this
system caused fluctuations in the ion current reflecting the possible
channel-drug interactions. Ertapenem which is a negatively
charged carbapenem [9] caused spontaneous blockage of the
ionic currents (Fig. 1b). The presence of antibiotic caused rapid
blockages of the monomers. These ion current fluctuation
increased with increasing concentration (see Text S1 and Fig.
S2). Furthermore, analysis at higher time resolution clearly
indicated complete monomer channel blockages. On average
0.5 mM ertapenem caused single monomer blockages and at an
increased concentration of 15 mM two monomers were blocked.
Interactions with cefepime, a zwitterionic cephalosporin [9], were
also detected, but the blockage events were shorter and less
frequent than those caused by ertapenem (Fig. 1c). In contrast
ceftazidime (Fig. 1d) and ampicillin (Fig. 1e) caused no
significant blockage of the ionic current indicating negligible
interaction with the channel. Similar characterization of OmpC,
for which a high-resolution structure has recently been resolved
[15], showed the same pattern of interaction with ertapenem,
cefepime, ceftazidime and ampicillin (data not shown).
The penetration of antibiotics into the channel can also be
measured by analysing the power density spectra of the ion
current. In Fig. 2a, a typical power density spectra of the ion
current fluctuations is shown. The figure shows clearly the effect of
different antibiotics: the presence of 10 mM ertapenem increased
the ion current noise 15 fold compared to background levels. In
contrast a much higher concentration of cefepime (25 mM) caused
only a doubling of the noise level. In the case of ampicillin and
ceftazidime (see Text S1 and Fig. S3) no excess noise was visible
(see Material and Methods for details). As previously shown the
excess noise was caused by perturbing the ion current inside the
channel in the presence of interacting antibiotics [17,23]. Channel
blocking by the antibiotic molecules was also quantified by using a
statistical analysis of the channel in its ‘un-occupied’ and
‘occupied’ (or blocked) states. The average residence time (t) of
each antibiotic in the Omp36 channel was obtained by single
exponential fitting of blockage time histograms with the distribu-
tion of dwell time in the blocked state (single channel analysis).
The t was 0.1460.02 ms for ertapenem and 0.1060.02 ms for
cefepime at 50 mV (Fig. 2b) (see Material and Methods for
details).
The strength of the ertapenem interactions allowed further
quantification of the ‘‘molecular dialogue’’ between this antibiotic
and the Omp36 channel. Fig. 2c shows the number blocking
events, which increase with increasing antibiotic concentration.
Following cis side addition of ertapenem more intense blocking was
observed compared to trans side addition. This indicated an
asymmetry in accessibility of the binding site and a lower energy
barrier from the cis side. As ertapenem is negatively charged, cis
side addition of the antibiotic along with the application of positive
voltages should favor translocation through the channel. Clearly,
we observed an enhanced rate of translocation when the antibiotic
was travelling from the cis to the trans side. However, blockage
events following trans side addition of ertapenem were less frequent
and voltage independent. This indicated a higher energy barrier
on the trans side and the electric field did not influence the rate of
translocation. In Fig. 2d, the average residence time of antibiotic
molecules in the channel measured at different voltages is shown.
It is important to note that the residence time was independent of
the concentration and of which side of the membrane the drug was
added. This indicated the presence of a single affinity site in the
channel according to the model described by Schwarz et al., 2003
[25].
We simplified the mathematical analysis by assuming the
presence of one affinity site within the channel, accessible from
both sides of the lipid membrane. The most important step that
determines antibiotic translocation is the entrance and exit rates.
The kinetic rate for channel entrance and exit allows estimation of
the net flux of antibiotics. For example when 1 mM ertapenem
was added to the cis side of the lipid membrane, the association
rate constant (kon) was 910061000 (Ms)
21 and the binding
constant (K) was 1.5060.05 M21 at an applied voltage of 50 mV.
Translocation of b-Lactams
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As previously shown the flux of antibiotic molecules per second is
given by [25,29,30] (see Material and Methods for details)
J~ kon=2,½ :Dc
This analysis concluded that, using a 1 mM ertapenem concen-
tration gradient across the channel, about 5 molecules were able to
translocate each Omp36 monomer per second. Blocking events in
the presence of cefepime were weak compared to ertapenem.
When 1 mM cefepime was added to the cis side of the lipid
membrane, the association rate constant (kon) was 10006100
(Ms)21 and the binding constant (K) was 0.260.02 M21 at an
applied voltage of 50 mV. The number of molecules translocated
was approximately 0.5 molecules per second per monomer.
Inspection of the above equation showed that translocation was
proportional to the on-rate [25,29,30]. The strength of an
antibiotic interaction with the affinity site of a channel greatly
influences the efficacy of its translocation [31,32]. Our data shows
that ertapenem interacts more strongly than cefepime with the
Omp36 channel (Fig 1, 2) and translocates the channel more
rapidly.
Rate of b-lactam Action on E. coli Expressing Omp36 as
the Sole Porin
The ability of b-lactams to traverse the outer membrane via
Omp36 channels was initially determined here using minimum
inhibitory concentration (MIC) assays. Omp36 (or OmpA as a
negative control – see Text S1) was expressed, on an IPTG
inducible plasmid, as the sole porin in an otherwise porin-null E.
coli strain (BL21Domp). Expression of Omp36 in the outer
Figure 1. Typical ion current recordings through a single Omp36 trimer reconstituted into planar lipid membranes. a. In the absence
of antibiotic, almost no channel closure was visible. b. Addition of 10 mM ertapenem on the cis side caused rapid closure of one monomer. c.
Addition of 25 mM cefepime on the cis side caused significantly less blocking compared to ertapenem. d. Addition of 25 mM ceftazidime on the cis
side caused no blocking. e. Addition of 25 mM ampicillin on the cis side caused no blocking. Membrane bathing solution was 1 M KCl (pH 6) and the
applied voltage was 50 mV. Chemical structure of antibiotics. f. Ertapenem g. Cefepime. The antibiotics are displayed in ’’balls and sticks’’ and
colored by atom type (oxygens in red, nitrogens in blue, carbons in cyan, sulfur in green, hydrogens in white).
doi:10.1371/journal.pone.0005453.g001
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membrane (see Text S1 and Fig. S1) resulted in an 8 fold
increase in sensitivity to ertapenem with an MIC of 0.5 mg ml21 in
IPTG-induced cultures compared to 4 mg ml21 in non-induced
cultures and those harboring vector only (see Text S1 and Table
S1). These data confirmed the involvement of Omp36 in b-lactam
susceptibility (see Text S1). We further compared the efficacy of
ertapenem and cefepime action by exposing bacterial cultures to
inhibitory concentrations of each b-lactam and observing the
percentage decreases in cell number (colony forming units,
cfu ml21) over time (Fig. 3). In the presence of either ertapenem
or cefepime, BL21Domp cultures expressing Omp36 as the sole
porin were depleted at a dramatically increased rate compared to
those expressing OmpA (Fig. 3) and, to a lesser extent, vector only
(data not shown). The action of ertapenem was observed to be
considerably faster than cefepime with a 90% decrease in cfu ml21
of Omp36 expressing cultures within 45 minutes and 90 minutes
respectively and a 99% decrease within 60 minutes and 150 min-
utes. Care must be taken when interpreting this data. The rapid
action of ertapenem could be attributed to high target affinity or
stability against b-lactamase degradation [33,34] (see Supplemen-
tary Data Section). However, with the use of stringent controls
imposed here, these results corroborate both MIC and electro-
physiological data, suggesting that efficient interactions of
ertapenem with an affinity site in the Omp36 channel confer
faster influx across the outer membrane via this porin, contributing
to the faster rate of action.
Discussion
This study deciphers a role for the enterobacterial porin,
Omp36 in antibiotic transport. Recent clinical studies of K.
pneumoniae infection observed that exposure to ertapenem promot-
ed drug resistance via the loss of OmpK36 [36–38]. Furthermore,
many recently evolved metallo-carbapenemases participating in
the enzymatic barrier require decreased porin expression to
effectively confer high-level carbapenem resistance [33]. Increas-
ing clinical studies report the down-regulation of porin expression,
or a shift favoring the expression of smaller or more restrictive
Figure 2. Kinetic analysis of antibiotic transport through Omp36. a. Power spectral densities of the excess noise in the ion current through a
single trimeric Omp36 channel in the presence two different antibiotics ertapenem and cefepime added to the cis side of the lipid membrane.
Smooth solid line through the spectra is Lorentzian fit with t=120 ms for ertapenem. b. Time histogram of Omp36 channel blockage in presence of
10 mM ertapenem (1) or 25 mM cefepime (2) added to the cis side of the lipid membrane. Solid line is the single exponential fit with characteristic
time t=128 ms(1) and 105 ms(2). c. The number of ertapenem blocking events per second was linear to ertapenem concentration and depended on
applied voltage and side of antibiotic addition (cis or trans side). d. Ertapenem residence time did not depend on the direction of the drug addition
(cis, trans or both sides) and it depended on the applied voltage. Average residence time decreased with increased applied voltage.
doi:10.1371/journal.pone.0005453.g002
Translocation of b-Lactams
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channels, as a response to antibiotherapy [4,13]. This results in
reduced membrane permeability that severely limits intracellular
drug accumulation, allowing the evolution and/or the acquisition
of other resistance mechanisms including target mutations,
enzymatic production, etc [13]. Such reports highlight the
importance of: 1) efficient influx through porins for b-lactams to
reach their target sites, and 2) a detailed understanding of this
dynamic and interactive process.
The pathway of the antibiotic molecule through the channel is
of crucial importance for the intracellular accumulation of
antibacterial drugs. It has become clear that the transport of b-
lactams or fluoroquinolones through OmpF-type porins is not by
passive diffusion through an inert tube, but involves specific
interactions with porin channels [17,19,23]. Due to the detailed
knowledge of its crystal structure most studies of antibiotic-porin
interactions so far have focused on OmpF from E. coli [14,39],
which is a major porin type expressed in vitro along with homologs
Omp35 and OmpK35 in Enterobacter and Klebsiella spp. However,
in vivo temperature and salt concentrations, favor the expression of
OmpC-type porins including Klebsiella pneumoniae OmpK36 and E.
aerogenes Omp36 [26,27] investigated here. Consequently, these are
the dominant porins in the patient body [3,4,13] and represent the
key strategic pathways for b-lactams and fluoroquinolones to
penetrate the bacterial cell during patient therapy. Our study
combines high resolution ion conductance measurements with
biological susceptibility assays to explore b-lactam translocation
properties through Omp36, a major porin of the MDR pathogen,
E. aerogenes. Using two representative b-lactam molecules, we
demonstrate that interaction with the channel correlates with
facilitated translocation through the porin and thus enhances the
transport efficiency. We hypothesize that there is a strong
interaction, involving hydrophobic and hydrogen bonds, between
ertapenem and specific aminoacid residues which constitute the
affinity site within Omp36. Ertapenem has a net negative charge
and two carboxylic groups are able to form hydrogen bonds with
the basic residues of the channel. In the case of cefepime (a
zwitterionic compound) we measured a lower channel affinity.
This is in agreement with previous molecular modeling of
cefepime in the constriction zone of OmpF [19] which is the
Omp35 homologue in E. coli [4]. For optimal permeation, a
balance is required between affinity and repulsion interactions at
key sites in the constriction zone. Our MIC data agree with the
electrophysiological results, showing stronger activity of ertapenem
than cefepime in bacterial cells expressing Omp36 as the sole
functional porin. In addition we have demonstrated the rate of
ertapenem antibiotic action on these cells to be strongly faster than
that of cefepime and that this is partly due to more rapid transport
through the porin.
A number of chemical and physical properties of antibiotic
molecules, such as size, hydrophobicity, stoichiometry and charge,
Figure 3. Influence of Omp36 Expression on the Rate of b-lactam Antibiotic Activity. Percentage decrease in cfu ml21 of BL21Domp
cultures expressing either Omp36 or OmpA following exposure to inhibitory concentrations of: a ertapenem (1 mg ml21), b ertapenem (4 mg ml21), c
cefepime (1 mg ml21). Experiments were repeated three times and error bars were indicated.
doi:10.1371/journal.pone.0005453.g003
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have been shown to influence their rate of permeation through
porin channels. For example, zwitterionic compounds have been
shown to penetrate proteoliposomes very rapidly [40] and have
induced increased ion flux perturbations through OmpF in lipid
bilayer models compared to other charged compounds. In
addition, large molecules, with bulky side-chains, such as azlocillin
and piperacillin have shown low permeation rates [17].
Efficient translocation through porins requires favorable
channel properties in addition to a streamlined antibiotic
molecule. As b-lactam molecules are similar in size to the channel
diameter, their passage is not a simple diffusion but rather a
gliding process along the pore wall. Within the constriction zone of
porin channels, strategically located residues create a strong
electrostatic field [15,17,36]. Key exposed residues particularly in
the internal loop 3 have been identified that transiently interact
with translocating molecules to strongly influence the rate of
permeation [17] and the antibiotic efficacy [19]. Site-directed
mutagenesis at such sites in E. coli OmpF and OmpC has been
shown to alter susceptibility to certain antibacterial molecules
[21,22,41,42]. OmpC and Omp36 porins harboring loop 3
mutations have been detected in a small number of resistant
clinical isolates of E. coli and E. aerogenes and may represent an
emerging bacterial drug resistance strategy in order to restrict
antibiotic influx [4,13]. Several biophysical investigations report
the interaction between ampicillin and OmpF during drug
diffusion in agreement with microbiological evidence [17,19,24].
In contrast, we have shown that ampicillin interaction with
Omp36 and OmpC is negligible. Nikaido and Rosenberg [43]
showed much restricted penetration of antibiotic molecules with
bulky side-chains and negative charges through OmpC than
through the wider OmpF channel. The recently resolved OmpC
crystal structure suggests that electrostatic pore potential and
specific atomic details inside the channel are the key parameters
distinguishing OmpC and OmpF rather than size [15]. This
reduced permeability through OmpC-type porins could explain
the shift from OmpF-type to OmpC-type expression observed in
clinical isolates during antibiotherapy as a strategy to limit
antibiotic influx [4,13]. Ertapenem and cefepime both possess
some of the star qualities required for rapid translocation. They
are small and compact, and interact with the channel significantly.
The recent description of the OmpC 3D structure [15], presents
the opportunity to decipher some of the detailed molecular criteria
involved in antibiotic diffusion through this porin group. Future
experiments should explore mutagenesis of key sites within the
Omp36 L3 loop to decipher exactly which residues are interacting
with each drug, and therefore, which aspects of the antibiotic
molecular structure drives rapid transport.
Our data suggest that for optimal permeation, a balance is
required between affinity and repulsion interactions at key sites in
the constriction zone. Consequently, the strength of interaction
has a major influence on rates of antibiotic penetration, ie
intracellular accumulation, and thus antibiotic efficiency [13].
A combination of efficient intracellular accumulation, stability
against b-lactamases and target affinity is exhibited by ertapenem
for effective antibiotic activity in bacteria. Crossing the outer
membrane is the first step in the b-lactam journey to its
periplasmic target site ensuring sufficient intracellular concentra-
tions for bacteriocidal activity. We report here that certain
molecular characteristics such as compact structure and a
particular pattern of ionic charges yet to be deciphered may
constitute a ‘passport’ for rapid travel through the porin
demonstrating that drug passive diffusion is in fact an interactive
process. Our approach may contribute to the rational design of
new antibiotic candidates against MDR pathogens and serve to
optimize influx by screening translocation rates of new com-
pounds, to determine whether they hold a valid passport for the
most efficient delivery to target sites.
Materials and Methods
Bacterial Strains and Culture Media
Cloning was performed using E. coli JM109. Protein expression
for purification and MIC experiments was performed in porin-null
E. coli BL21(DE3)omp8 (DlamB, ompF::Tn5, DompA, DompC )
referred to in the text as BL21Domp [28]. Bacteria were grown in
Luria bertani (LB) broth (Difco) except during MIC experiments,
in which Muller Hinton (MH) broth (Difco) was used. Transfor-
mants were selected on Luria Bertani agar (Difco) containing
relevant antibiotics (kanamycin (50 mg ml21) and or ampicillin
(100 mg ml21) (Sigma)).
Cloning and Outer Membrane Expression of omp36 and
ompA
The omp36 (1137 bp) and ompA (1085 bp) genes were amplified,
including their signal peptide sequences, from E. aerogenes ATCC
strain 13048 using PCR, and restriction sites were added
(underlined in the primer sequence) to each end using primers
59omp36BamHI (59-GTTAGCGGATCCATGAAAGTTAAAG-
TACTGTCCCTC 39) and 39omp36HindIII (59-GCGTTAG-
CAAGCTTCAGCGTGCTTAGAACTGGTA-39) and 59ompA-
BamHI (59-GTTAGCGGATCCATGAAAAAGACAGCTATC-
GC-39) and 39ompAHindIII (59-GCGTTAGCAAGCTTG-
GAAACTTAAGCCTGCG-39) respectively. PrimeSTARTMHS
DNA polymerase (Takara) was used to amplify products by PCR
according to the manufacturers instructions (cycling conditions;
melting at 98uC, 10 s; annealing at 58uC, 10 s, extension at 72uC,
60 s). Purified PCR products were digested using BamHI and
HindIII (New England Biolabs) and cloned into the expression
vector pColdIV (4359 bp) (Takara), using T4 Ligase (NEB) to
create pColdIVomp36 and pColdIVompA. Plasmid constructs were
confirmed by sequencing (GenomeExpress), using the primer pair
pColdF (59-ACGCCATATCGCCGAAAGG-39) and pColdR (59-
GGCAGGGATCTTAGATTCTG-39) [44] then transformed
into BL21Domp. Transformants were grown to early-exponential
phase (OD600 0.4) in LB at 37uC before chilling to 15uC and
adding 1 mM IPTG (Eurogentec) for 18 hours. Expression was
confirmed by SDS PAGE and immunodetection.
Minimum Inhibitory Concentration Assays
BL21Domp cultures harboring pColdIV, pColdIVomp36 or
pColdIVompA, were grown to OD600 0.4 in LB containing
appropriate antibiotics. Cultures were split into 2 flasks, 1 was
induced with IPTG (1 mM) for 1 h and the other was not.
Bacteria were then subcultured into MH broth with or without
IPTG (0.5 mM) and b-lactamase quenchers tazobactam, clavu-
lanic acid and cloxacillin (4 mg ml21 each) at OD600 0.001
containing no antibiotics. 2-fold dilution series of each antibiotic
studied were prepared and added to 1 ml aliquots of bacterial
suspensions in MH. Assays were incubated for 18–24 h, 37uC.
Each assay was repeated independently 3 times and results were
classified according to the Antibiogram Committee of the French
Society for Microbiology (http://www.sfm.asso.fr).
Rate of Antibiotic Action Assays
BL21Domp E. coli cultures harboring either pColdIVomp36 or
pColdIVompA, were prepared as for MIC assays. In trials
performed using the MIC for cultures producing OmpA
(4 mg ml21), Omp36 expressing cultures were depleted to un-
Translocation of b-Lactams
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detectable levels within 20 min (see Text S1 and Fig. S1). In
order to accurately quantify the rate of action over a number of
time points, all induced and diluted cell suspensions (OD600 0.01)
were exposed to 26 the MIC for cultures producing Omp36
(1 mg ml21). At 15–30 min time intervals, 10-fold dilution series of
exposed cultures were prepared with LB and spread onto LB agar
containing appropriate antibiotics. Plates were incubated over-
night at 37uC for 18 h and colonies were counted. Colony forming
units (cfu/ml) were calculated for each time point and plotted as
the percentage decrease in cfu/ml compared to t = 0. All
experiments were repeated independently at least 4 times.
Outer Membrane Extraction
The method for extracting outer membranes (OM) was
modified from Bolla [45]. Briefly, induced cultures (1 L) were
harvested by centrifugation (10,0006g, 20 min, 4uC). Bacterial
cells were disrupted in 50 mM sodium phosphate buffer, (NaPi)
pH 7.4 by sonication using the Branson Sonifer 450 (762 min,
output level 5) on ice and total membranes collected by
ultracentrifugation (100,0006g, 1 h, 4uC). Inner membrane
proteins were solubilized by agitation with sodium lauryl
sarcosinate, 0.15% w/v (sigma) in NaPi (50 mM, pH 7.4, room
temperature, 30 min). OM proteins were harvested by ultracen-
trifugation (100,0006g, 1 h, 4uC). OM expression of Omp36 was
assessed using SDS PAGE and immunodetection.
SDS PAGE and Western Blotting
Bacterial protein extracts were analyzed on SDS-PAGE gels
containing 10% acrylamide. Samples were denatured in Laemmli
loading dye containing 2% SDS and heated 36 to 95uC [11].
Protein size was estimated by comparison with pre-stained low-
range molecular weight marker (BioRad). Proteins were stained
using Coomassie Brilliant Blue R-250.
For immunodetection, proteins were electrotransfered onto
nitrocellulose membranes (Schleicher & Schlull, Keene, NH, USA)
in transfer buffer (20 mM Tris, 150 mM glycine, 20% isopropa-
nol, 0.05% SDS). Membranes were blocked using 4% milk in Tris-
buffered sodium (TBS: 50 mM Tris-HCl, 150 mM NaCl, pH 8).
Polyclonal antibodies were used for detection, anti-F4 antibody
directed against a small peptide of the conserved internal loop 3
for porin and anti-OmpA antibody directed against OmpA of E.
coli for OmpA [11,18]. Detection of antigen-antibody complexes
was performed with alkaline phosphatase-conjugated AffinitiPure
goat anti-rabbit IgG antibodies (Jackson ImmunoResearch, West
Grove PA, USA) using BCIP and NBT (Sigma) according to the
manufacturers instructions.
Purification of Omp36
Purification methods were developed from Bolla [45] and
Garavito and Rosenbusch [46]. OM extracts were washed with
0.5% octyl-POE (Bachem AG, Bubendorf, Switzerland) in NaPi
(50 mM, pH 7.4). Selective extraction of Omp36 was performed
by solubilization from OM preparations using 1% octyl-POE+-
NaCl (1 M) at 37uC, 1 h with shaking. Unsolubilized proteins
were removed by ultracentrifugation (100,0006g, 1 h at 4uC).
Extraction from the pellet was repeated twice using the same
conditions. Supernatants were pooled and concentrated using
YM-30 centricon filters and NaCl was removed using Hi-Trap de-
salting columns (GE Healthcare). Omp36 was purified from
solubilized protein extracts using a Resource Q ion exchange
column (Amersham Biosciences). The column was equilibrated
with NaPi, pH 7.4 containing 1.2% POE and 10 mM NaCl.
Extracts were loaded at a flow rate of 2 ml min21, monitoring
conductivity and OD at 280 nm at all times using Akta Explorer
10 apparatus. Omp36 was eluted from the column using a linear
gradient (12 CV) from 10 mM to 1 M NaCl. Fractions containing
Omp36 were verified by SDS-PAGE and immonoblotting.
Single channel measurements and antibiotic interaction
Virtually solvent-free lipid bilayer membranes were formed as
previously described by Montal and Mueller [47]. To form planar
lipid bilayers with the monolayer opposition technique, we used
1,2-Diphytanoyl-sn-Glycero-3-Phosphatidylcholine (Avantipolar
lipids). Two symmetrical compartments of a Teflon chamber each
with a solution volume of 0.25 ml of KCl (1 M, pH 6) were
separated by a 25 mm thick Teflon film (Goodfellow, Cambrid-
ge,UK) containing a round aperture of 60–80 mm diameter. The
aperture was pretreated with 1% hexadecane in pentane. Ag/
AgCl electrodes were used to detect ion currents (World Precision
Instruments, Sarasota FL, USA). The cis electrode was grounded
while the trans electrode was connected to the head stage of an
Axopatch 200B amplifier (Axon Instruments, Foster City, CA).
The applied membrane voltage refers to the difference between
the cis and trans side potentials. The membrane capacitance was
50–100 picofarads. Single channel insertion was achieved by
adding 1–2 ml of Omp36 extract (18 ng ml21) containing 0.6%
Octyl POE to the chamber. Single channel insertion was
facilitated by applying a membrane voltage of 200 mV and
mixing the contents of the chamber. Measurements were
performed with an Axopatch 200B amplifier in the voltage clamp
mode. Under the applied voltage, protein insertion was easily
detected by current increase. The porin was always added to the
cis-side of the chamber. It is interesting to note that single porin
insertion was always asymmetric in contrast to multi-channel
recording leading to a more equally distributed orientation.
Channel conductance is slightly higher at positive voltage
compared to negative voltage in all experiments, which can be
used as the test for the direction of channel insertion. Signal was
filtered using a low-pass Bessel filter at 10 kHz and recorded to PC
at 50 kHz sampling frequency. Data analysis was performed using
Clampfit software (Axon Instruments, Inc.). All experiments were
carried out at room temperature.
Ion current fluctuations in the presence of various antibiotics
were measured at an applied transmembrane voltage. Concen-
trated aliquots of antibiotic solutions were added to the lipid
chamber, mixed very well, and incubated for 10 minutes for
complete diffusion in the chamber prior to recording. Antibiotic
stock solutions were prepared in 1 M KCl buffered by MES. The
pH of the solution was measured and adjusted after the
preparation of the stock solution and continuously measured at
different concentrations in the course of the experiment and after
completing the experiment. Blockage events occurred following
addition of antibiotics ertapenem and cefepime to either the cis or
trans side of the artificial membranes. These blockages reveal the
current state of the ‘‘binding’’ site and allow analysis of the
occupation on a single molecular level. The first step is to analyse
the statistic of the time histogram. If the interaction of the
antibiotic with the channel can be described by a simple two-state
Markovian (no hysteresis) a single exponential decay is observed.
The average residence time of antibiotic was calculated using
single exponential fitting of blockage time histograms (Fig. 2b). At
low concentration, [c]%koff/kon, the characteristic time was close
to the average residence time of the drug (t) thus allowing us to use
the following equations: t<koff21, and kon = v/(3[c]) where v is the
number of binding events and [c] was the antibiotic concentration.
A similar approach was employed for the estimation of ampicillin
and moxifloxacin translocation rates through the E. coli OmpF
channel [24,31].
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In the case where single blockage events are less pronounced,
the power density spectra is more suited to analyse interactions
[29]. Electronically it is rather favorable to average over typical
occurring frequencies and the above exponential decay will lead to
a Lorentzian in the power density spectra. The experimental
parameter is the corner frequency at which a Lorentzian decayed
to half of its original value vc = kon [c]+koff.
The spectrum of ion current fluctuations was fitted to the
Lorentzian model: S (f) = S (0)/(1+(f/fc)2), where S (0) was the low-
frequency spectral density and fc was the corner frequency, giving
the relaxation time constant defined as t= 1/2pfc. It is interesting
to note that the concentration dependent corner frequency
obtained from a Lorentzian fit of the power spectrum yielded
the same results (data not shown). The corner frequency increased
in a concentration dependent manner allowing determination of
the on and off rates of ertapenem into the affinity site of the
Omp36 channel. In contrast only little increase was visible for
cefepime and none for ampicilin and ceftazidime.
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